BPC-157 + TB-500 MedCore
BPC-157 + TB-500 MedCore combination, 5mg + 5mg. 98% purity and CoA/HPLC documents. For research purposes only.
€109.00
Recovery research comparison
BPC-157 vs TB-500
Compare distinct experimental pathways and the current catalog destinations while preserving uncertainty.
| Comparison point | BPC-157 + TB-500 MedCore | TB-500 MedCore |
|---|---|---|
| Research mechanism | A combined catalog format containing two distinct research peptides; the format itself does not establish synergy. | A thymosin-beta-4-related peptide fragment studied in cell and tissue models. |
| Current catalog formats | ||
| Current EUR price | €109.00 | €105.00 |
| Research focus | Separate gastric-peptide and thymosin-related research questions. | Actin, cell migration and tissue-model research. |
| Evidence context | BPC-157 evidence is predominantly preclinical and clinical safety data are lacking; evidence for the combination is uncertain. | The broader thymosin beta 4 literature does not automatically establish the effects, safety or suitability of this catalog format. |
Current catalog entries
TB-500 MedCore
TB-500 MedCore 10mg in a pre-filled pen format. 98% purity and CoA/HPLC documents. For research purposes only.
€105.00